Jaye Thompson bought $13k of GLSI
VP Clinical Reg Affairs at Greenwich LifeSciences, Inc.. 1,000 shares at an average of $12.91, traded Nov 21, 2024, filed Nov 25, 2024.
Score components
- +15RoleOfficer
- 0Trade size$13k at market
- -5Relative to holdingsUnder 1% of holdings (0.4%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -12.4%, 3m -15.0%, 6m -29.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-24-047527, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | POpen-market purchase Common Stock | +1,000 | $12.91 | $13k | 264,148 | Nov 25, 2024 |
Related signals
Other insiders at Greenwich LifeSciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $30k 2,200 shares | +0% | |
| 28Weak | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $20k 1,500 shares | +0% | |
| 29Weak | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $47k 3,600 shares | +0% | |
| 32Weak | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $54k 1,800 shares | +0% | |
| 34Weak | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $80k 2,900 shares | +0% | |
| 38Weak | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $92k 4,300 shares | +0% | |
| 33Weak | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $63k 2,900 shares | +0% | |
| 32Weak | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $52k 4,100 shares | +0% | |
| 49Moderate | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $39k 4,600 shares | +0% | |
| 52Moderate | GLSIbuy Greenwich LifeSciences, Inc. | Snehal Patel CEO and CFO | $89k 10,600 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.